Le Lézard
Classified in: Oil industry, Environment, Science and technology, Business, Covid-19 virus
Subject: JVN

HONEYWELL EXITS SAVANNAH RIVER NUCLEAR SOLUTIONS JOINT VENTURE


CHARLOTTE, N.C., July 3, 2023 /PRNewswire/ -- Honeywell (Nasdaq: HON) today announced it has exited the Savannah River Nuclear Solutions joint venture through the sale of its membership interests to partners Fluor and Huntington Ingalls.

"We are confident that Fluor and Huntington Ingalls will continue to deliver long term value to the Savannah River Site as a significant portion of its scope shifts to major capital construction and start-up of plutonium production activities," said David Johnson, Vice President of Honeywell Federal Solutions. "Honeywell remains deeply committed to the success of the Department of Energy and will continue to partner with them on opportunities that align with Honeywell's core capabilities and strategic objectives." 

Honeywell (www.honeywell.com) delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom. 

This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are those that address activities, events or developments that management intends, expects, projects, believes or anticipates will or may occur in the future. They are based on management's assumptions and assessments in light of past experience and trends, current economic and industry conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ significantly from those envisaged by our forward-looking statements. We do not undertake to update or revise any of our forward-looking statements, except as required by applicable securities law. Our forward-looking statements are also subject to risks and uncertainties, including the impact of the COVID-19 pandemic and the Russia-Ukraine conflict, that can affect our performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal commitment, expectation, or prospect set forth in this release can or will be achieved. Any forward-looking plans described herein are not final and may be modified or abandoned at any time. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

Contacts:


Media

Investor Relations

Caitlin Leopold

Sean Meakim

(980) 287-5730

(704) 627-6200

[email protected]

[email protected] 

 

SOURCE Honeywell


These press releases may also interest you

at 01:05
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm currently deployed in over 500 million devices, is shipping its AI Virtual Proximity Sensortm INNER BEAUTY® on the newly announced Moondrop...

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:49
A news report from chinadaily.com.cn: Young people play a pivotal role in innovation and deserve more support that encourages them to...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...

at 00:12
The 46th and 47th International Collegiate Programming Contest (ICPC) World Finals concluded on April 18. A total of 263 teams from over 50 countries took part in the five-hour competition. The ICPC World Finals in Egypt was a postponed and combined...



News published on and distributed by: